An open study of remoxipride, a benzamide derivative, in schizophrenia

Abstract

Remoxipride is a novel substituted benzamide derivative with specific dopamine-(D2)-receptor blocking properties and selective action on brain mesolimbic functions. Ten inpatients with a DSM-III diagnosis of schizophrenia were treated with the drug in a 6-week open-label study. After 1 week placebo washout, the patients were given stepwise increased doses… (More)
DOI: 10.1007/BF00431718

Topics

1 Figure or Table

Cite this paper

@article{Lindstrm1985AnOS, title={An open study of remoxipride, a benzamide derivative, in schizophrenia}, author={Linda Lindstr{\"o}m and G. Besev and G{\"o}ran Stening and Erik Widerl{\"o}v}, journal={Psychopharmacology}, year={1985}, volume={86}, pages={241-243} }